RIABNI Trademark

Trademark Overview

On Monday, November 5, 2018, a trademark application was filed for RIABNI with the United States Patent and Trademark Office. The USPTO has given the RIABNI trademark a serial number of 88182290. The federal status of this trademark filing is REGISTERED as of Tuesday, August 2, 2022. This trademark is owned by Amgen Inc.. The RIABNI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of inflammatory and auto-immune diseases and disorders; pharmaceutical preparations for treatment of arthritis; pharmaceutical preparations for treatment of diseases and disorders of the immune system and joints; pharmaceutical preparations for treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), and microscopic polyangiitis (MPA)
riabni

General Information

Serial Number88182290
Word MarkRIABNI
Filing DateMonday, November 5, 2018
Status700 - REGISTERED
Status DateTuesday, August 2, 2022
Registration Number6809212
Registration DateTuesday, August 2, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 10, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment of inflammatory and auto-immune diseases and disorders; pharmaceutical preparations for treatment of arthritis; pharmaceutical preparations for treatment of diseases and disorders of the immune system and joints; pharmaceutical preparations for treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), and microscopic polyangiitis (MPA)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 20, 2018
Primary Code005
First Use Anywhere DateMonday, January 4, 2021
First Use In Commerce DateMonday, January 4, 2021

Trademark Owner History

Party NameAmgen Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events

Event DateEvent Description
Tuesday, August 2, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 2, 2022REGISTERED-PRINCIPAL REGISTER
Saturday, June 25, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, June 24, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 21, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 16, 2022USE AMENDMENT FILED
Thursday, June 16, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, May 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 2, 2022SOU EXTENSION 5 GRANTED
Tuesday, April 26, 2022SOU EXTENSION 5 FILED
Monday, May 2, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 26, 2022TEAS EXTENSION RECEIVED
Saturday, September 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 16, 2021SOU EXTENSION 4 GRANTED
Thursday, September 16, 2021SOU EXTENSION 4 FILED
Thursday, September 16, 2021TEAS EXTENSION RECEIVED
Thursday, May 6, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 6, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, May 6, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 6, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 5, 2021SOU EXTENSION 3 GRANTED
Monday, April 5, 2021SOU EXTENSION 3 FILED
Monday, April 5, 2021TEAS EXTENSION RECEIVED
Saturday, October 31, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 29, 2020SOU EXTENSION 2 GRANTED
Thursday, October 29, 2020SOU EXTENSION 2 FILED
Thursday, October 29, 2020TEAS EXTENSION RECEIVED
Thursday, April 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 28, 2020SOU EXTENSION 1 GRANTED
Tuesday, April 28, 2020SOU EXTENSION 1 FILED
Tuesday, April 28, 2020TEAS EXTENSION RECEIVED
Tuesday, November 5, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 21, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 8, 2019ASSIGNED TO LIE
Monday, July 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 25, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, July 25, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 25, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, July 25, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, March 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 13, 2018NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, December 13, 2018PRIORITY ACTION E-MAILED
Thursday, December 13, 2018PRIORITY ACTION WRITTEN
Tuesday, December 11, 2018ASSIGNED TO EXAMINER
Tuesday, November 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 8, 2018NEW APPLICATION ENTERED

Related Keywords

riabni pharmaceutical treatment preparations arthritis disorders diseases polyangiitis immune leukemia rheumatoid